Who Owns Monogram Technologies?

• Parent Company: Zimmer Biomet
• Ownership Type: Wholly owned
• Acquisition Year: 2025
• Company Type: Publicly Traded
• Stock Ticker: NASDAQ: ZBH

• Founded: 2012
• Founders: Monogram Technologies Inc (internal development)
• Acquired by Zimmer Biomet: 2025

• Founded: 1927
• Headquarters: Warsaw, Indiana, USA
• Company Type: Publicly Traded
• Stock: NASDAQ: ZBH
• Revenue: $8.5 billion (FY2025)
• Employees: ~25,000

Visit Zimmer Biomet website

• Headquarters: Warsaw, Indiana, USA
• Manufacturing / Operations: United States, Europe, Asia

Monogram Technologies operates under Zimmer Biomet's comprehensive sustainability framework, which integrates environmental responsibility, ethical business practices, and social impact across medical device manufacturing and surgical instrument operations. As a medical device company, Monogram Technologies focuses on sustainable manufacturing, responsible sourcing, and ethical healthcare practices.

Environmental Sustainability in Medical Device Manufacturing: Monogram Technologies has implemented comprehensive environmental initiatives across its manufacturing facilities, including energy-efficient production processes, waste reduction programs, and sustainable material sourcing. The company invests in advanced manufacturing technologies that reduce energy consumption while maintaining the precision and quality required for surgical instruments.

Sustainable Materials and Responsible Sourcing: Monogram Technologies prioritizes sustainable materials in its surgical instrument production, including recycled metals where appropriate, environmentally friendly coatings, and responsibly sourced raw materials. The company works with suppliers who adhere to environmental standards and ethical business practices throughout the supply chain.

Medical Device Environmental Compliance: The company maintains strict compliance with environmental regulations governing medical device manufacturing, including proper disposal of manufacturing waste, chemical management protocols, and emissions control systems. Monogram Technologies follows industry best practices for environmental stewardship in medical device production.

Sustainable Packaging Solutions: Monogram Technologies has implemented sustainable packaging initiatives for its surgical instruments, including recyclable packaging materials, reduced packaging waste, and environmentally friendly packaging designs that maintain product sterility and protection while minimizing environmental impact.

Workplace Safety and Employee Welfare: Monogram Technologies prioritizes workplace safety across its manufacturing facilities, implementing comprehensive safety programs, ergonomic work environments, and employee training programs. The company maintains strong employee relations and provides competitive wages and benefits to support workforce stability and professional development.

Healthcare Ethics and Patient Safety: Monogram Technologies maintains strong ethical standards in medical device manufacturing, prioritizing patient safety, product quality, and regulatory compliance. The company follows industry best practices for medical device ethics, including transparent reporting, quality assurance, and continuous improvement processes.

Community Engagement and Healthcare Access: Monogram Technologies participates in community outreach programs, healthcare education initiatives, and partnerships with medical institutions to support surgical education and improve healthcare access in underserved communities.

Monogram Technologies has received recognition within the medical device industry for product innovation, manufacturing excellence, and contributions to surgical instrument technology, though awards focus more on industry achievements than consumer brand recognition.

Medical Device Innovation Awards: The company has been recognized for innovation in surgical instrument design, ergonomic improvements, and advanced manufacturing technologies that enhance surgical precision and surgeon experience. These innovations have been acknowledged by medical device industry organizations and surgical societies.

Manufacturing Excellence Recognition: Monogram Technologies' manufacturing facilities have received awards for quality management systems, precision manufacturing processes, and operational excellence in medical device production. The company's commitment to quality and consistency has been acknowledged by industry certification bodies.

Product Quality and Design Awards: The company's surgical instruments have received recognition for superior design, durability, and performance characteristics that meet the demanding requirements of surgical procedures and medical professionals.

Industry Partnership Recognition: Monogram Technologies has received awards from healthcare institutions and surgical centers for collaborative product development and reliable supply chain partnerships that support surgical innovation and improved patient outcomes.

Regulatory Compliance Recognition: The company has been acknowledged for maintaining high standards of regulatory compliance and quality assurance in medical device manufacturing, meeting or exceeding industry requirements for safety and effectiveness.

Technology Innovation Awards: Monogram Technologies has received recognition for implementing advanced manufacturing technologies, including precision engineering processes and quality control systems that enhance surgical instrument production and quality consistency.

Workplace Excellence: The company has been recognized for workplace safety programs, employee development initiatives, and manufacturing excellence that support operational efficiency and employee retention in the competitive medical device industry.

Monogram Technologies has maintained a relatively clean operational record regarding major recalls and controversies, though like all medical device companies, the company has faced some challenges related to regulatory compliance and industry standards.

Medical Device Regulatory Compliance: Monogram Technologies has faced occasional regulatory scrutiny regarding medical device compliance and quality assurance procedures. These issues have typically been resolved through cooperation with regulatory agencies and implementation of enhanced quality control systems.

Product Quality Concerns: The company has occasionally faced concerns regarding surgical instrument quality and performance consistency, leading to enhanced testing procedures and quality assurance improvements to maintain product reliability and customer satisfaction.

Manufacturing Quality Issues: Like all medical device manufacturers, Monogram Technologies has faced challenges related to manufacturing quality control, requiring periodic process improvements and enhanced testing protocols to ensure product consistency and regulatory compliance.

Supply Chain Disruptions: The company has faced challenges related to supply chain disruptions, particularly for raw materials and specialized components required for surgical instrument manufacturing. These disruptions have occasionally affected production schedules and product availability.

Competitive Market Pressures: Monogram Technologies operates in a highly competitive medical device market, facing pressure from other surgical instrument manufacturers and changing healthcare industry requirements that affect product development and market positioning.

Regulatory Scrutiny: The company has faced regulatory attention regarding medical device approvals and compliance with FDA requirements, though these issues have been resolved through standard regulatory processes and quality system improvements.

Intellectual Property Disputes: Monogram Technologies has occasionally faced intellectual property challenges related to surgical instrument designs and manufacturing processes, requiring legal defense of proprietary technologies and design innovations.

Healthcare Industry Changes: The company has faced challenges related to evolving healthcare industry requirements, including changing hospital procurement practices, cost containment pressures, and shifts in surgical procedure preferences that affect product demand and market positioning.